Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Melander

Showing results (261-270 of 272) with videos related to

Pageof 28
Sort By:
European Journal of Clinical Pharmacology|February 9, 2000
Pharmacodynamics and pharmacokinetics of intravenous glibenclamide in Caucasian and Chinese patients with type-2 diabetesA Jönsson, J C Chan, T Rydberg, et al.
European Journal of Clinical Pharmacology|February 24, 2001
Effects and pharmacokinetics of oral glibenclamide and glipizide in Caucasian and Chinese patients with type-2 diabetesA Jönsson, J C Chan, T Rydberg, et al.
BMJ (Clinical Research Ed.)|August 24, 1996
Incidence of myocardial infarction in elderly men being treated with antihypertensive drugs: population based cohort studyJ Merlo, J Ranstam, H Liedholm, et al.
Scandinavian Journal of Public Health|March 3, 2001
Mortality in elderly men with low psychosocial coping resources using anxiolytic-hypnotic drugsJ Merlo, P O Ostergren, N O Månsson, et al.
European Journal of Clinical Pharmacology|May 25, 2001
Association of outpatient utilisation of non-steroidal anti-inflammatory drugs and hospitalised heart failure in the entire Swedish populationJ Merlo, K Broms, U Lindblad, et al.
Diabetes, Obesity & Metabolism|January 5, 2011
Can sulphonylurea addition to lifestyle changes help to delay diabetes development in subjects with impaired fasting glucose? The Nepi ANtidiabetes StudY (NANSY)U Lindblad, G Lindberg, N-O Månsson, et al.
Nature|September 25, 1980
VIP occurs in intrathyroidal nerves and stimulates thyroid hormone secretionB Ahrén, J Alumets, M Ericsson, et al.
Acta Diabetologica|January 1, 1991
Effect of sulphonylurea on glucose-stimulated insulin secretion in healthy and non-insulin dependent diabetic subjects: a dose-response studyL C Groop, K Ratheiser, L Luzi, et al.
European Journal of Clinical Pharmacology|January 1, 1996
Increased risk of ischaemic heart disease mortality in elderly men using anxiolytics-hypnotics and analgesics. Results of the 10-year follow-up of the prospective population study "Men born in 1914", Malmo, SwedenJ Merlo, B Hedblad, M Ogren, et al.
Diabetes Care|August 1, 1990
Acute actions of sulfonylurea drugs during long-term treatment of NIDDMO K Faber, H Beck-Nielsen, C Binder, et al.
Pageof 28

Showing results (261-270 of 272) with videos related to

Sort By:
Pageof 28
European Journal of Clinical Pharmacology|February 9, 2000
Pharmacodynamics and pharmacokinetics of intravenous glibenclamide in Caucasian and Chinese patients with type-2 diabetesA Jönsson, J C Chan, T Rydberg, et al.
European Journal of Clinical Pharmacology|February 24, 2001
Effects and pharmacokinetics of oral glibenclamide and glipizide in Caucasian and Chinese patients with type-2 diabetesA Jönsson, J C Chan, T Rydberg, et al.
BMJ (Clinical Research Ed.)|August 24, 1996
Incidence of myocardial infarction in elderly men being treated with antihypertensive drugs: population based cohort studyJ Merlo, J Ranstam, H Liedholm, et al.
Scandinavian Journal of Public Health|March 3, 2001
Mortality in elderly men with low psychosocial coping resources using anxiolytic-hypnotic drugsJ Merlo, P O Ostergren, N O Månsson, et al.
European Journal of Clinical Pharmacology|May 25, 2001
Association of outpatient utilisation of non-steroidal anti-inflammatory drugs and hospitalised heart failure in the entire Swedish populationJ Merlo, K Broms, U Lindblad, et al.
Diabetes, Obesity & Metabolism|January 5, 2011
Can sulphonylurea addition to lifestyle changes help to delay diabetes development in subjects with impaired fasting glucose? The Nepi ANtidiabetes StudY (NANSY)U Lindblad, G Lindberg, N-O Månsson, et al.
Nature|September 25, 1980
VIP occurs in intrathyroidal nerves and stimulates thyroid hormone secretionB Ahrén, J Alumets, M Ericsson, et al.
Acta Diabetologica|January 1, 1991
Effect of sulphonylurea on glucose-stimulated insulin secretion in healthy and non-insulin dependent diabetic subjects: a dose-response studyL C Groop, K Ratheiser, L Luzi, et al.
European Journal of Clinical Pharmacology|January 1, 1996
Increased risk of ischaemic heart disease mortality in elderly men using anxiolytics-hypnotics and analgesics. Results of the 10-year follow-up of the prospective population study "Men born in 1914", Malmo, SwedenJ Merlo, B Hedblad, M Ogren, et al.
Diabetes Care|August 1, 1990
Acute actions of sulfonylurea drugs during long-term treatment of NIDDMO K Faber, H Beck-Nielsen, C Binder, et al.
Pageof 28